Researchers at GENyO develop the first liquid biopsy-based algorithm capable of diagnosing and classifying COPD

Researchers from GENyO and ibs.GRANADA have developed EPIMETRICThe first liquid biopsy-based algorithm capable of diagnosing and classifying chronic obstructive pulmonary disease (COPD) through a blood test. This advance represents a significant step toward more accurate and less invasive tools for addressing a disease that affects millions of people worldwide and remains underdiagnosed.

The research has been led by Dr. María José Serrano, attached to the Pathological Anatomy Unit of the Virgen de las Nieves University Hospital in Granada, and developed by the research groups A06 Clinical Oncology and Liquid Biopsy y A04-Digital and Computational Pathology, Immunopathology and Cancer from ibs.GRANADA. Researchers from the Genomics and Oncological Research Center (GENyO) also participated in the study, reinforcing the multidisciplinary nature of this work, as well as Doctors Bernardino Alcázar-Navarrete and Pedro J. Romero, specialists in pulmonology and leading figures in the study of COPD.

COPD is a chronic respiratory disease that makes breathing difficult and is one of the leading causes of illness and death worldwide. Its diagnosis is usually based on functional tests such as spirometry, which have limitations and contribute to many cases going undetected.

Read the full article: https://www.ibsgranada.es/investigadores-del-ibs-granada-desarrollan-el-primer-algoritmo-basado-en-biopsia-liquida-capaz-de-diagnosticar-y-clasificar-la-epoc/